Advertisement

Latest News

Q1 2026 Recap: Psychiatry News and Updates

17 minutes ago

FDA approvals, at-home neuromodulation, phase 3 psychedelic data, and rising AI therapy use impacted the psychiatry field in the first quarter of 2026.

Self-Administered Etripamil for PSVT Has Minimal Blood Pressure, Heart Rate Effects, With Nerendra Singh, MD

17 minutes ago

Singh discusses his analysis of all 3 parts of the NODE-301 phase 3 trial, investigating the recently approved CBB’s potential risk of hypotension.

Q1 2026 Recap: Gastroenterology News and Updates

3 hours ago

Q1 2026 GI updates include advances in IBD and IBS therapies, long-term data, and new insights into access challenges for younger patients.

12 New Recommendations For Anticoagulant Prophylaxis in Pediatric Patients at Risk for Venous Thromboembolism

3 hours ago

Gray Areas and Controversies in the 2025 ACS Guidelines, With Michelle O’Donoghue, MD, MPH

3 hours ago

O’Donoghue addresses the inherent limitations in the ACS guidelines, from the constant influx of further research to the ambiguity of certain treatment recommendations.

Advertisement
Advertisement